Siemens (NYSE:SI) Healthineers said today it closed its acquisition of the Epocal point-of-care blood diagnostic business from Alere and Abbott (NYSE:ABT) for an undisclosed amount.
Siemens Healthineers said it will integrate Epocal’s portfolio into its POC Ecosystem solution to offer customized testing and touted that the two lines would “integrate seamlessly.”
“Health networks have varying needs for blood gas testing across physicians’ offices, clinics, emergency departments, laboratories and even in ambulances. Having any one solution is limiting and may not meet all patient needs, which is why customized testing solutions are so important for improving patient care. With a complete offering for blood gas diagnostics, we can help healthcare providers and point-of-care coordinators improve their workflows by offering the right test in the right setting at the right time,” Siemens point-of-care diag biz prez Peter Koerte said in a press release.
Epocal produces the handheld wireless Epoc blood analysis system designed to analyze blood gas, electrolyte and metabolite results in approximately 30 seconds after blood sample introduction, Siemens said. The system is comprised of the Epoc room-temperature stable BEM test card, Epoc reader and Epoc host2 mobile computer. A range of tests can be performed on the BGEM card, the company added.
Siemens announced the deal to acquire Epocal from Alere in July as it looked to clear regulatory hurdles in its acquisition by Abbott, which closed early last month.
The post Siemens Healthineers closes Epocal buy appeared first on MassDevice.
from MassDevice http://ift.tt/2iSX8Il
Cap comentari:
Publica un comentari a l'entrada